Science Explorer Back to mapMap
Discussion
Company · Heidelberg · Germany

Phenex Pharmaceuticals (Germany)

phenex-pharma.comROR OpenAlex
Research works
59
▼ 91% vs 2018-21
Citations
3.1k
52.8 per fractional work
Top-10% rate
2.9%
all institutions 10.0%
Open access
45%
world 40%
International
33%
world 18%
Phenex Pharmaceuticals (Germany)

Not ranked overall: Phenex Pharmaceuticals (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Phenex Pharmaceuticals (Germany) work in?

In all years, 47% of research at Phenex Pharmaceuticals (Germany) is in Life Sciences, 47% in Health Sciences. Its largest fields are Medicine (46%), Biochemistry, Genetics and Molecular Biology (27%), Immunology and Microbiology (11%). It does 2.6× the world's share of Life Sciences.

Life Sciences: 28 fractional works · 47.4% of its workBiochemistry, Genetics and Molecular Biology: 16 fractional works · 27.4% of its workMolecular Biology: 11 fractional works · 19.3% of its workGenetics: 1 fractional works · 2.5% of its workCancer Research: 1 fractional works · 2.4% of its workBiochemistry: 1 fractional works · 1.4% of its workCell Biology: 1 fractional works · 1.1% of its workPhysiology: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.3% of its workImmunology and Microbiology: 6 fractional works · 10.7% of its workImmunology: 5 fractional works · 8.3% of its workVirology: 1 fractional works · 1.7% of its workParasitology: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 4 fractional works · 7.2% of its workBiological Psychiatry: 3 fractional works · 4.4% of its workCellular and Molecular Neuroscience: 1 fractional works · 1.5% of its workNeurology: 0 fractional works · 0.6% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.5% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 1.8% of its workPharmacology: 1 fractional works · 1.8% of its workAgricultural and Biological Sciences: 0 fractional works · 0.3% of its workHealth Sciences: 28 fractional works · 46.8% of its workMedicine: 27 fractional works · 46.4% of its workOncology: 8 fractional works · 13.1% of its workEpidemiology: 5 fractional works · 8.8% of its workPhysiology: 2 fractional works · 4.0% of its workHepatology: 2 fractional works · 3.8% of its workSurgery: 2 fractional works · 3.2% of its workInfectious Diseases: 1 fractional works · 2.2% of its workHematology: 1 fractional works · 1.8% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.4% of its workRheumatology: 1 fractional works · 1.2% of its workPsychiatry and Mental health: 1 fractional works · 1.1% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 1.1% of its workGenetics: 1 fractional works · 0.9% of its workPharmacology: 0 fractional works · 0.8% of its workPathology and Forensic Medicine: 0 fractional works · 0.8% of its workNeurology: 0 fractional works · 0.4% of its workComplementary and alternative medicine: 0 fractional works · 0.3% of its workImmunology and Allergy: 0 fractional works · 0.3% of its workNephrology: 0 fractional works · 0.3% of its workUrology: 0 fractional works · 0.2% of its workDermatology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.4% of its workNursing: 0 fractional works · 0.4% of its workNutrition and Dietetics: 0 fractional works · 0.4% of its workPhysical Sciences: 3 fractional works · 5.0% of its workComputer Science: 1 fractional works · 1.8% of its workComputational Theory and Mathematics: 1 fractional works · 1.8% of its workChemistry: 1 fractional works · 1.6% of its workOrganic Chemistry: 1 fractional works · 1.6% of its workEngineering: 0 fractional works · 0.6% of its workSafety, Risk, Reliability and Quality: 0 fractional works · 0.6% of its workPhysics and Astronomy: 0 fractional works · 0.6% of its workAstronomy and Astrophysics: 0 fractional works · 0.6% of its workEnvironmental Science: 0 fractional works · 0.3% of its workEcology: 0 fractional works · 0.3% of its workMaterials Science: 0 fractional works · 0.2% of its workSocial Sciences: 0 fractional works · 0.7% of its workSocial Sciences: 0 fractional works · 0.7% of its workPolitical Science and International Relations: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.2% of its workALL ITS WORKPhenexPharmaceuticals…59fractional works, all years
Life Sciences47%Physical Sciences5%Health Sciences47%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 14 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1627.4%
    2. Immunology and Microbiology610.7%
    3. Neuroscience47.2%
    4. Pharmacology, Toxicology and Pharmaceutics11.8%
    5. Agricultural and Biological Sciences00.3%
    1. Medicine2746.4%
    2. Nursing00.4%
    1. Computer Science11.8%
    2. Chemistry11.6%
    3. Engineering00.6%
    4. Physics and Astronomy00.6%
    5. Environmental Science00.3%
    6. Materials Science00.2%
    1. Social Sciences00.7%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Phenex Pharmaceuticals (Germany)?

Ranked on the quality score, Ulrich Deuschle, Claus Kremoser and Eva Hambruch lead among researchers whose main affiliation is Phenex Pharmaceuticals (Germany).

  1. 1 Ulrich Deuschle Germany · #581,472 worldwide 3.2k citations · 97 works
  2. 2 Claus Kremoser Germany · #600,212 worldwide 2.8k citations · 52 works
  3. 3 Eva Hambruch Germany · #2,532,632 worldwide 816 citations · 27 works
  4. 4 Martin Hornberger Germany · #2,954,579 worldwide 485 citations · 24 works
  5. 5 Christoph Steeneck Germany · #3,414,952 worldwide 620 citations · 22 works
  6. 6 Manfred Birkel Germany · #3,894,481 worldwide 244 citations · 23 works
  7. 7 Olaf D. Kinzel Germany · #4,936,583 worldwide 1.9k citations · 58 works
All ranked researchers at Phenex Pharmaceuticals (Germany)

What are the most cited papers from Phenex Pharmaceuticals (Germany)?

The most cited paper from Phenex Pharmaceuticals (Germany) is "Genome-wide, large-scale production of mutant mice by ENU mutagenesis" (Martin Hrabě de Angelis et al., 2000), with 677 citations. Next come "Protein Kinase G from Pathogenic Mycobacteria Promotes Survival Within Macrophages" (594) and "Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β" (437).

Most cited papers
#PaperReleasedCitations
1 Genome-wide, large-scale production of mutant mice by ENU mutagenesis Martin Hrabě de Angelis et al. · Nature Genetics Open access Aug 2000 677
2 Protein Kinase G from Pathogenic Mycobacteria Promotes Survival Within Macrophages Anne Walburger, Anil Koul, Giorgio Ferrari et al. · Science 24 May 2004 594
3 Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β Justin M. Nussbaum, Stephan Schilling, Holger Cynis et al. · Nature Open access May 2012 437
4 Interplay between mycobacteria and host signalling pathways Anil Koul, Thomas Herget, Bert Klebl et al. · Nature Reviews Microbiology Review 20 Feb 2004 370
5 An efficient proteomics method to identify the cellular targets of protein kinase inhibitors Klaus Godl, Josef B. Wissing, Alexander Kurtenbach et al. · Proceedings of the National Academy of Sciences Open access 10 Dec 2003 337
All 59 most cited papers, with filters and sorting

Which keywords describe research at Phenex Pharmaceuticals (Germany)?

By fractional works in all years, weighted toward what it does more of than the world: Immune Response, Cancer Therapy, Inflammation, Nuclear Receptors, Cancer, Metabolic Regulation, Neuroinflammation and Immune Activation.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation7▲ 5.0×23 topics
  2. Immune Response6▲ 17×9 topics
  3. Epidemiology6▲ 2.5×16 topics
  4. Cancer Therapy6▲ 16×11 topics
  5. Nuclear Receptors5▲ 47×5 topics
  6. Cancer5▲ 6.0×15 topics
  7. Oxidative Stress4▲ 4.2×12 topics
  8. Metabolic Regulation4▲ 23×3 topics
  9. Neuroinflammation4▲ 23×4 topics
  10. Immune Activation4▲ 66×2 topics
  11. ATP-dependent Transporters4▲ 116×1 topic
  12. Multidrug Resistance4▲ 100×1 topic
  13. Regulatory T Cells3▲ 52×2 topics
  14. Schizophrenia3▲ 42×2 topics
  15. Cytokines3▲ 19×3 topics
  16. Microglia3▲ 58×2 topics
  17. Immune System3▲ 14×3 topics
  18. Metabolic Syndrome3▲ 5.5×5 topics
  19. Treatment3▲ 3.7×5 topics
  20. Depression3▲ 6.2×3 topics
  21. Hepatocellular Carcinoma3▲ 21×2 topics
  22. Insulin Resistance3▲ 9.8×3 topics
  23. Tumor Microenvironment3▲ 13×5 topics
  24. Maternal Immune Activation3▲ 110×1 topic
  25. Metabolism3▲ 6.8×7 topics
  26. Tryptophan Metabolism3▲ 110×1 topic
  27. Antiviral Therapy2▲ 27×3 topics
  28. Hepatic Steatosis2▲ 27×2 topics
  29. TGF-ß2▲ 24×2 topics
  30. IL-172▲ 156×1 topic
  31. TH17 Cells2▲ 156×1 topic
  32. Transcriptional Regulation2▲ 16×6 topics
  33. Vaccine2▲ 9.9×3 topics
  34. NAFLD2▲ 34×1 topic
  35. NASH2▲ 34×1 topic
  36. Antiretroviral Therapy2▲ 15×3 topics
  37. Oncogenic Mutations2▲ 79×2 topics
  38. Apoptosis2▲ 8.8×5 topics
  39. Calcium Signaling2▲ 24×3 topics
  40. Cell Migration2▲ 37×2 topics

Which research topics does Phenex Pharmaceuticals (Germany) publish most on?

By volume in 2022-now: Inflammatory mediators and NSAID effects, Psoriasis: Treatment and Pathogenesis, Cytokine Signaling Pathways and Interactions and Sulfur Compounds in Biology.

Inflammatory mediators and NSAID effects: 0 fractional worksPsoriasis: Treatment and Pathogenesis: 0 fractional worksCytokine Signaling Pathways and Interactions: 0 fractional worksSulfur Compounds in Biology: 0 fractional worksPotato Plant Research: 0 fractional worksDrug-Induced Hepatotoxic…0Drug-Induced Hepatotoxicity and Protection: 0 fractional worksLiver Disease Diagnosis and Treatment: 0 fractional worksCholesterol and Lipid Metabolism: 0 fractional worksDrug Transport and Resis…0Drug Transport and Resistance Mechanisms: 0 fractional works
PharmacologyImmunologyOncologyBiochemistry3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Inflammatory mediators and NSAID effects Pharmacology 0 works
  2. 2 Psoriasis: Treatment and Pathogenesis Immunology 0 works
  3. 3 Cytokine Signaling Pathways and Interactions Oncology 0 works
  4. 4 Sulfur Compounds in Biology Biochemistry 0 works
  5. 5 Potato Plant Research Food Science 0 works
  6. 6 Drug-Induced Hepatotoxicity and Protection Pharmacology 0 works
  7. 7 Liver Disease Diagnosis and Treatment Epidemiology 0 works
  8. 8 Cholesterol and Lipid Metabolism Surgery 0 works
  9. 9 Drug Transport and Resistance Mechanisms Oncology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available44.9%not open55.1%

World: 40% of research is openly available.

with international co-authors32.6%domestic only67.4%

World: 18% is written across borders.

How has Phenex Pharmaceuticals (Germany)'s research output changed?

Output in 2022-2025 was 91% lower than in 2018-2021.

still counting200020052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Phenex Pharmaceuticals (Germany) as a percentage of every work published that year, 0.0000060% in 2024.

still counting0.00020%0.00040%Phenex Pharmaceuticals (Germany)0.0000085% in 2025200020102020

Fractional works of Phenex Pharmaceuticals (Germany) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Heidelberg

All research institutions in Heidelberg

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Phenex Pharmaceuticals (Germany). Posts are plain text and can be reported.